Zero Staff Time Cognitive Screening for Post-Acute Care
Key Facts
- GIA enables zero staff time cognitive screening in post-acute care settings.
- Screens for cognitive decline with 70.8% accuracy.
- GIA integrates with leading EHR systems such as PointClickCare and Epic.
- Screens take under 5 minutes, with results in 60 seconds.
- Screens for 46 conditions, including anxiety (77.5% accuracy) and depression (81.6% accuracy).
Staff shortages plague post-acute care. Can tech ease the burden? GIA™, a Digital Human®, offers a way to screen residents for potential cognitive decline without requiring any direct staff involvement. This approach enhances resident care and addresses staffing challenges.
What Factors Contribute to Staffing Shortages in Post-Acute Care?
The post-acute care sector faces a severe staffing crisis. Nurses and CNAs are stretched thin, struggling to meet the increasing demands of a growing patient population. This shortage directly impacts the quality of care, making it difficult to provide the necessary attention and monitoring for each resident. Essential tasks, such as cognitive screenings, are often delayed or overlooked, leading to missed diagnoses and delayed interventions. The pressure on staff also contributes to burnout and turnover, further exacerbating the problem. Traditional cognitive assessments require dedicated staff time, pulling nurses away from direct patient care. This is unsustainable in the current environment. A method that minimizes staff involvement is essential to maintain high-quality care and alleviate the burden on overworked professionals. GIA™ offers a practical method that allows staff to focus on their core responsibilities while ensuring all residents receive timely cognitive screenings.
How Does GIA™ Provide Zero Staff Time Cognitive Screening?
GIA™ represents a significant change in cognitive screening for post-acute care. Unlike traditional methods that demand significant staff time, GIA™ conducts the entire screening process independently. Using a Samsung Health Grade Galaxy device with Samsung Knox, GIA™ engages residents in a natural, conversational assessment, evaluating their cognitive function through speech biomarkers. The entire interaction takes under 5 minutes, and results are available in just 60 seconds. GIA™'s screening for cognitive decline has 70.8% accuracy. GIA™ does not diagnose; instead, she identifies residents who may benefit from further evaluation by a clinician. This ‘human-in-the-loop’ approach ensures that clinical judgment remains central to the diagnostic process. A clinician reviews and approves the results before they enter the clinical record. GIA™ screens for 46 conditions (21 live, 25 coming soon), including depression (81.6% accuracy) and anxiety (77.5% accuracy). GIA™ SPEAKS 92 languages, ensuring inclusivity for diverse patient populations. Consider the time saved and the improved resident care that can be achieved with zero staff time cognitive screening.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
How Does GIA™ Integrate with Existing EHR Systems?
The value of any screening tool is significantly enhanced when it easily integrates with existing electronic health record (EHR) systems. GIA™ is designed to do just that. She integrates with leading EHR platforms such as PointClickCare, Epic, Cerner, MatrixCare, and American HealthTech. This integration allows for the automatic documentation of screening results directly into the resident's chart, eliminating the need for manual data entry and reducing the risk of errors. Furthermore, GIA™ can administer Activities of Daily Living (ADLs) and Instrumental Activities of Daily Living (IADLs) assessments, with results written back to the EHR. This complete approach provides a view of the resident's functional abilities and cognitive status, enabling clinicians to make more informed decisions.
Why is Addressing Undiagnosed Cognitive Impairment Important?
Mild Cognitive Impairment (MCI) affects an estimated 12 million Americans, yet a staggering 92% are unaware of their condition. Early detection is important for managing cognitive decline and improving patient outcomes. GIA™ helps address this critical gap by providing a convenient and accessible screening tool that can identify individuals at risk. By implementing no staff cognitive screening with GIA™, post-acute care facilities can proactively identify residents who may be experiencing cognitive decline or other undiagnosed conditions, enabling timely interventions and improved quality of life. Early detection also allows for better care planning and resource allocation, ensuring that residents receive the support they need to maintain their independence and well-being. GIA™ helps facilities adhere to CMS F-Tag 758, which focuses on providing appropriate care and services to residents with cognitive impairments.
How Does GIA™ Enhance Accuracy and Clinical Confidence?
While GIA™ automates the screening process, it is important to emphasize that she does not replace clinical judgment. GIA™'s screening for cognitive decline has 70.8% accuracy. GIA™ is 510(k) registered and HIPAA compliant, ensuring the privacy and security of patient data. The system uses over 2,500 speech biomarkers to analyze cognitive function, providing a assessment. A clinician reviews and approves the results before they enter the clinical record. GIA™ serves as a tool to augment clinical expertise, providing objective data to support decision-making. The system is designed to enhance, not replace, the role of healthcare professionals in providing high-quality care.
Conclusion
Implementing zero staff time cognitive screening with GIA™ offers a method to the staffing challenges facing the industry while enhancing resident care. By automating the screening process and integrating easily with existing EHR systems, GIA™ frees up valuable staff time, reduces the risk of missed diagnoses, and improves overall efficiency. Request a demo today to explore the possibilities and see GIA™ in action.
Sources & References
- Centers for Medicare & Medicaid Services (CMS). Quality measures and star ratings. cms.gov
- Alzheimer’s Association. 2024 Alzheimer’s Disease Facts and Figures. alz.org/facts
- Scienza Health clinical validation: 12.3M longitudinal PAC/LTC patient records, 27B clinical events.
- U.S. Food & Drug Administration. 510(k) device registration database. fda.gov
David Kaiser is the Founder and CEO of Scienza Health, where he leads the development of GIA®, a Digital Human® that screens for 46 cognitive and neurological conditions using 2,500+ speech biomarkers in under 5 minutes. The platform is 510(k) registered, HIPAA compliant, and has been validated on 12.3M patient records and 27B clinical events.
Frequently Asked Questions
How does GIA™ ensure resident privacy and data security?
GIA™ is fully HIPAA compliant and uses Samsung Health Grade Galaxy devices with Samsung Knox to ensure the highest level of data security. All resident data is encrypted and protected in accordance with industry best practices. We are committed to maintaining the privacy and confidentiality of all patient information. Our system is designed to meet the stringent security requirements of the healthcare industry.
What happens if GIA™ identifies a resident who may have cognitive decline?
GIA™ does not diagnose. If GIA™ identifies a resident who may be at risk, the results are flagged and communicated to the appropriate clinical staff. The clinician then reviews the results and determines the next steps, which may include further evaluation or referral to a specialist. GIA™ provides valuable data to inform clinical decision-making, but the final diagnosis and treatment plan are always determined by a qualified healthcare professional.
How much does GIA™ cost?
The cost of GIA™ depends on the specific needs and size of your facility. We offer flexible pricing options to accommodate different budgets. The potential cost savings from reduced staff time and improved efficiency can often offset the investment in GIA™. Contact us today for a personalized quote and to learn more about how GIA™ can benefit your organization.
The Clinical Signal
Hear the latest episode on clinical AI screening in post-acute care.